跳至主要内容
临床试验/NCT01603888
NCT01603888已完成不适用

Molecular Forms of Plasma and Urinary B-type Natriuretic Peptide and Its N-terminal Prohormone in Health and Disease in Pediatric Cardiology

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
molecular forms of BNP in healthy newborns, infants and children with heart disease.

研究概览

简要总结

B-type natriuretic Peptide (BNP) is a cardiac hormone secreted from the cardiac myocytes in response to volume load. Plasma levels of BNP, as measured by immunoassay methods, are elevated in patients with heart diseases. However, the biological effects of BNP are blunted in heart failure and other cardiac conditions. Moreover, the peptide levels are also elevated in non cardiac conditions such as the neonatal period, sepsis and renal failure. Recent investigations suggest alteration of the peptide molecular structure in heart failure. These alterations may explain, at least partially, the reduced biological activities of BNP in heart failure.

Immunoreactive BNP and NT-proBNP have been identified in human urine. It has been suggested that urinary BNP correlates with plasma BNP, and may serve as a non-invasive measure for this cardiac marker. It is unclear what BNP fractions are cleared in the urine in health and disease.

The aim of the proposed studies is to elucidate precisely the molecular form of BNP in various disease and specific physiological states in plasma and urine of infants and children.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy newborn infants with normal pregnancy and delivery
  • Premature infants
  • Infants and children with heart disease who have NT-proBNP levels taken as part of cardiac evaluation

排除标准

  • Patients with non cardiac disease (renal, hepatic)
  • Patients with acute urinary disease or other acute non-cardiac diseases.

结局指标

主要结局

molecular forms of BNP in healthy newborns, infants and children with heart disease.

时间窗: one year

Quantification of the specific molecular forms will be performed by liquid chromatography coupled to mass spectrometry.

次要结局

  • BNP presence and define its molecular forms in urine of healthy newborns,infants and children with heart disease. BNP presence and define its molecular forms in urine of healthy newborns and infant and children with heart disease. BNP presence and(one year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Molecular Forms of Plasma and Urinary B-type... | 临床试验